Showing 1 - 10 of 29
We investigated the stock price behavior of public pharmaceutical and biotechnology companies upon approval of a drug by the Food and Drug Administration (FDA). Using event study methodology, we examine the reaction caused by the approval, seperating it from the asset price movements caused by...
Persistent link: https://www.econbiz.de/10010765339
We investigated the stock price behavior of public pharmaceutical and biotechnology companies upon approval of a drug by the Food and Drug Administration (FDA). Using event study methodology, we examine the reaction caused by the approval, separating it from the asset price movements caused by...
Persistent link: https://www.econbiz.de/10009958446
Persistent link: https://www.econbiz.de/10004157377
The goal of this paper is to examine the impact of Initial Public Offerings (IPO) on the investment strategies of young entrepreneurial firms. Hypotheses are developed from the finance, strategy and top management team literature. These are then tested using multivariate methods in order to...
Persistent link: https://www.econbiz.de/10010765340
In this paper, a set of hypotheses relating competitive and cooperative business strategies and technology strategies to new venture performance are developed. These hypotheses are tested using data collected from the Initial Public Offering (IPO) documents of a sample of 52 new ventures in the...
Persistent link: https://www.econbiz.de/10009191853
Persistent link: https://www.econbiz.de/10005354083
Persistent link: https://www.econbiz.de/10005354311
Persistent link: https://www.econbiz.de/10005462069
Persistent link: https://www.econbiz.de/10005235690
Persistent link: https://www.econbiz.de/10002083179